Strategy or symptom: Semantic clustering and risk of Alzheimer’s disease-related impairment

References

• Alonso, R., Perez de Isla, L., Muñiz-Grijalvo, O., Diaz-Diaz, J., & Mata, P. (2018). Familial hypercholesterolaemia diagnosis and management. European Cardiology Review, 13(1), 14. https://doi.org/10.15420/ecr.2018:10:2
   PubMed Web of Science ®Google Scholar
• Alzheimer’s Disease International. 2019. World Alzheimer Report 2019: Attitudes to dementia.
   Google Scholar
• Bäckman, L. (1992). Memory training and memory improvement in Alzheimer’s disease: Rules and exceptions. Acta Neurologica Scandinavica. Supplementum, 85(S139), 84–89. https://doi.org/10.1111/j.1600-0404.1992.tb04461.x
   Google Scholar
• Baddeley, A. D. (2001). Is working memory still working? The American Psychologist, 56(11), 851–864. https://doi.org/10.1037/0003-066x.56.11.851
   PubMed Web of Science ®Google Scholar
• Barulli, D., Rakitin, B., Lemaire, P., & Stern, Y. (2013). The influence of cognitive reserve on strategy selection in normal aging. Journal of the International Neuropsychological Society, 19(7), 841–844. https://doi.org/10.1017/S1355617713000593
   PubMed Web of Science ®Google Scholar
• Baudic, S., Barba, G., Thibaudet, M., Smagghe, A., Remy, P., & Traykov, L. (2006). Executive function deficits in early Alzheimer’s disease and their relations with episodic memory. Archives of Clinical Neuropsychology, 21(1), 15–21. https://doi.org/10.1016/j.acn.2005.07.002
   PubMed Web of Science ®Google Scholar
• Bone, A. E., Gomes, B., Etkind, S. N., Verne, J., Murtagh, F. E., Evans, C. J., & Higginson, I. J. (2018). What is the impact of population ageing on the future provision of end-of-life care? Population-based projections of place of death. Palliative Medicine, 32(2), 329–336. https://doi.org/10.1177/0269216317734435
   PubMed Web of Science ®Google Scholar
• Craig, C. L., Marshall, A. L., Sjstrm, M., Bauman, A. E., Booth, M. L., Ainsworth, B. E., PRATT, M., EKELUND, U., YNGVE, A., SALLIS, J. F., & Oja, P. (2003). International physical activity questionnaire: 12-country reliability and validity. Medicine and Science in Sports and Exercise, 35(8), 1381–1395. https://doi.org/10.1249/01.MSS.0000078924.61453.FB
   PubMed Web of Science ®Google Scholar
• Delis, D. C., Fine, E. M., Stricker, J. L., Houston, W. S., Wetter, S. R., Cobell, K., Jacobson, M. W., Salmon, D. P., & Bondi, M. W. (2010). Comparison of the traditional recall-based versus a new list-based method for computing semantic clustering on the California verbal learning test: Evidence from Alzheimer’s disease. The Clinical Neuropsychologist, 24(1), 70–79. https://doi.org/10.1080/13854040903002232
   PubMed Web of Science ®Google Scholar
• Dubois, B., Feldman, H. H., Jacova, C., Cummings, J. L., DeKosky, S. T., Barberger-Gateau, P., Delacourte, A., Frisoni, G., Fox, N. C., Galasko, D., Gauthier, S., Hampel, H., Jicha, G. A., Meguro, K., O’Brien, J., Pasquier, F., Robert, P., Rossor, M., Salloway, S., de Souza, L. C., & Scheltens, P. (2010). Revising the definition of Alzheimer’s disease: A new lexicon. The Lancet Neurology, 9(11), 1118–1127. https://doi.org/10.1016/S1474-4422(10)70223-4
   PubMed Web of Science ®Google Scholar
• Dunn, C. J., Duffy, S. L., Hickie, I. B., Lagopoulos, J., Lewis, S. J. G., Naismith, S. L., & Shine, J. M. (2014). Deficits in episodic memory retrieval reveal impaired default mode network connectivity in amnestic mild cognitive impairment. NeuroImage: Clinical, 4, 473–480. https://doi.org/10.1016/j.nicl.2014.02.010
   PubMed Web of Science ®Google Scholar
• Esiri, M. M., & Chance, S. A. (2012). Cognitive reserve, cortical plasticity and resistance to Alzheimer’s disease. Alzheimer’s Research & Therapy, 4(2), 7. https://doi.org/10.1186/alzrt105
   PubMed Web of Science ®Google Scholar
• Fagundo, A. B., López, S., Romero, M., Guarch, J., Marcos, T., & Salamero, M. (2008). Clustering and switching in semantic fluency: Predictors of the development of Alzheimer’s disease. International Journal of Geriatric Psychiatry, 23(10), 1007–1013. https://doi.org/10.1002/gps.2025
   PubMed Web of Science ®Google Scholar
• Gauthier, S., Albert, M., Fox, N., Goedert, M., Kivipelto, M., Mestre-Ferrandiz, J., & Middleton, L. T. (2016). Why has therapy development for dementia failed in the last two decades? Alzheimer’s & Dementia, 12(1), 60–64. https://doi.org/10.1016/j.jalz.2015.12.003
   PubMed Web of Science ®Google Scholar
• Gavett, B. E., Gurnani, A. S., Saurman, J. L., Chapman, K. R., Steinberg, E. G., Martin, B., & Stern, R. A. (2016). Practice effects on story memory and list learning tests in the neuropsychological assessment of older adults. Plos One, 11(10). https://doi.org/10.1371/journal.pone.0164492
   Web of Science ®Google Scholar
• Gavett, B. E., Ozonoff, A., Doktor, V., Palmisano, J., Nair, A. K., Green, R. C., Jefferson, A. L., & Stern, R. A. (2010). Predicting cognitive decline and conversion to Alzheimer’s disease in older adults using the NAB list learning test. Journal of the International Neuropsychological Society, 16(4), 651–660. https://doi.org/10.1017/S1355617710000421
   PubMed Web of Science ®Google Scholar
• Gavett, B. E., Poon, S. J., Ozonoff, A., Jefferson, A. L., Nair, A. K., Green, R. C., & Stern, R. A. (2009). Diagnostic utility of the NAB list learning test in Alzheimer’s disease and amnestic mild cognitive impairment. Journal of the International Neuropsychological Society, 15(1), 121. https://doi.org/10.1017/S1355617708090176
   PubMed Web of Science ®Google Scholar
• Genin, E., Hannequin, D., Wallon, D., Sleegers, K., Hiltunen, M., Combarros, O., Bullido, M. J., Engelborghs, S., De Deyn, P., Berr, C., Pasquier, F., Dubois, B., Tognoni, G., Fiévet, N., Brouwers, N., Bettens, K., Arosio, B., Coto, E., Del Zompo, M., Epelbaum, J., … Campion, D. (2011). APOE and Alzheimer disease: A major gene with semi-dominant inheritance. Molecular Psychiatry, 16(9), 903–907. https://doi.org/10.1038/mp.2011.52
   PubMed Web of Science ®Google Scholar
• Gold, C. (2008). Memory loss in Alzheimer’s disease: Implications for development of therapeutics. Expert Review of Neurotherapeutics, 8(12), 1879–1891. https://doi.org/10.1586/14737175.8.12.1879
   PubMedGoogle Scholar
• Greenwood, P. M., Espeseth, T., Lin, M. K., Reinvang, I., & Parasuraman, R. (2014). Longitudinal change in working memory as a function of APOE genotype in midlife and old age. Scandinavian Journal of Psychology, 55(3), 268–277. https://doi.org/10.1111/sjop.12123
   PubMed Web of Science ®Google Scholar
• Griffith, H. R., Netson, K. L., Harrell, L. E., Zamrini, E. Y., Brockington, J. C., & Marson, D. C. (2006). Amnestic mild cognitive impairment: Diagnostic outcomes and clinical prediction over a two-year time period. Journal of the International Neuropsychological Society, 12(2), 166–175. https://doi.org/10.1017/S1355617706060267
   PubMed Web of Science ®Google Scholar
• Jacobs, D. M., Rakitin, B. C., Zubin, N. R., Ventura, P. R., & Stern, Y. (2001). Cognitive correlates of mnemonics usage and verbal recall memory in old age. Neuropsychiatry, Neuropsychology, and Behavioral Neurology, 14(1), 15–22. https://www.ncbi.nlm.nih.gov/pubmed/11234905
   PubMedGoogle Scholar
• Jessen, F. (2019). Early detection of Alzheimer’s disease and approaches for prevention. Gesundheitsforschung Gesundheitsschutzhttps, 62(3), 255–260. https://doi.org/10.1007/s00103-019-02877-2
   PubMed Web of Science ®Google Scholar
• Lange, K. L., Bondi, M. W., Salmon, D. P., Galasko, D., Delis, D. C., Thomas, R. G., & Thal, L. J. (2002). Decline in Verbal memory during preclinical Alzheimer’s disease: Examination of the effect of APOE genotype. Journal of the International Neuropsychological Society, 8(7), 943–955. https://doi.org/10.1017/S1355617702870096
   PubMed Web of Science ®Google Scholar
• Malek-Ahmadi, M., Raj, A., & Small, B. J. (2011). Semantic clustering as a neuropsychological predictor for amnestic-MCI. Aging, Neuropsychology, and Cognition, 18(3), 280–292. https://doi.org/10.1080/13825585.2010.540642
   PubMed Web of Science ®Google Scholar
• Manning, J. R., & Kahana, M. J. (2012). Interpreting semantic clustering effects in free recall. Memory, 20(5), 511–517. https://doi.org/10.1080/09658211.2012.683010
   PubMed Web of Science ®Google Scholar
• McLaughlin, P. M., Wright, M. J., LaRocca, M., Nguyen, P. T., Teng, E., Apostolova, L. G., & Woo, E. (2014). The ‘Alzheimer’s type’ profile of semantic clustering in amnestic mild cognitive impairment. Journal of the International Neuropsychological Society, 20(4), 402–412. https://doi.org/10.1017/S135561771400006X
   PubMed Web of Science ®Google Scholar
• Nao, J., Sun, H., Wang, Q., Ma, S., Zhang, S., Dong, X., … Zheng, D. (2017). Adverse Effects of the apolipoprotein E ε4 Allele on episodic memory, task switching and gray matter volume in healthy young adults. Frontiers in Human Neuroscience, 11, 346. https://doi.org/10.3389/fnhum.2017.00346
   PubMed Web of Science ®Google Scholar
• Nebel, R. A., Aggarwal, N. T., Barnes, L. L., Gallagher, A., Goldstein, J. M., Kantarci, K., Mallampalli, M. P., Mormino, E. C., Scott, L., Yu, W. H., Maki, P. M., & Mielke, M. M. (2018). Understanding the impact of sex and gender in Alzheimer’s disease: A call to action. Alzheimer’s & Dementia, 14(9), 1171–1183. https://doi.org/10.1016/j.jalz.2018.04.008
   PubMed Web of Science ®Google Scholar
• O’Donoghue, M. C., Murphy, S. E., Zamboni, G., Nobre, A. C., & Mackay, C. E. (2018). APOE genotype and cognition in healthy individuals at-risk of Alzheimer’s disease: A review. Cortex, 104, 103–123. https://doi.org/10.1016/j.cortex.2018.03.025
   Web of Science ®Google Scholar
• Roses, A. D., & Saunders, A. M. (1994). APOE is a major susceptibility gene for Alzheimer’s disease. Current Opinion in Biotechnology, 5(6), 663–667. https://doi.org/10.1016/0958-1669(94)90091-4
   PubMedGoogle Scholar
• Sampedro, F., Vilaplana, E., de Leon, M. J., Alcolea, D., Pegueroles, J., Montal, V., Carmona-Iragui, M., Sala, I., Sánchez-Saudinos, M.-B., Antón-Aguirre, S., Morenas-Rodríguez, E., Camacho, V., Falcón, C., Pavía, J., Ros, D., Clarimón, J., Blesa, R., Lleó, A., & Fortea, J. (2015). APOE -by-sex interactions on brain structure and metabolism in healthy elderly controls. Oncotarget, 6(29), 26663–26674. https://doi.org/10.18632/oncotarget.5185
   PubMedGoogle Scholar
• Schrijnemaekers, A. M., de Jager, C. A., Hogervorst, E., & Budge, M. M. (2006). Cases with mild cognitive impairment and Alzheimer’s disease fail to benefit from repeated exposure to episodic memory tests as compared with controls. Journal of Clinical and Experimental Neuropsychology, 28(3), 438–455. https://doi.org/10.1080/13803390590935462
   PubMed Web of Science ®Google Scholar
• Shinohara, M., Murray, M. E., Frank, R. D., & Takahisa, K. (2016). Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer’s disease. Acta Neuropathologica, 132(2), 225–234. https://doi.10.1007/s00401-016-1580-y
   Web of Science ®Google Scholar
• Singh, P. P., Singh, M., & Mastana, S. S. (2006). APOE distribution in world populations with new data from India and the UK. Annals of Human Biology, 33(3), 279–308. https://doi.org/10.1080/03014460600594513
   PubMed Web of Science ®Google Scholar
• Sliwinski, M. J., Hofer, S. M., Hall, C., Buschke, H., & Lipton, R. B. (2003). Modeling memory decline in older adults: The Importance of preclinical dementia, attrition, and chronological age. Psychology and Aging, 18(4), 658–671. https://10.1037/0882-7974.18.4.658
   PubMed Web of Science ®Google Scholar
• Stern, R. A., & White, T. (2003). NAB, neuropsychological assessment battery: Administration, scoring, and interpretation manual. Psychological Assessment Resources.
   Google Scholar
• Stern, Y. (2009). Cognitive reserve. Neuropsychologia, 47(10), 2015–2028. https://doi.org/10.1016/j.neuropsychologia.2009.03.004
   PubMed Web of Science ®Google Scholar
• Stern, Y. (2012). Cognitive Reserve in ageing and Alzheimer’s disease. The Lancet Neurology, 11(11), 1006–1012. https://doi.org/10.1016/S1474-4422(12)70191-6
   PubMed Web of Science ®Google Scholar
• Thai, C., Lim, Y. Y., Villemagne, V. L., Laws, S. M., Ames, D., & Ellis, K. A. (2015). Amyloid-related memory decline in preclinical Alzheimer’s disease is dependent on APOE ε4 and is detectable over 18-months. Plos One, 10(10). https://doi.org/10.1371/journal.pone.0139082
   Web of Science ®Google Scholar
• Udeh-Momoh, C., Price, G., Ropacki, M. T., Ketter, N., Andrews, T., Arrighi, H. M., Brashear, H. R., Robb, C., Bassil, D. T., Cohn, M., Curry, L. K., Su, B., Perera, D., Giannakopoulou, P., Car, J., Ward, H. A., Perneczky, R., Novak, G., & Middleton, L. (2019). Prospective evaluation of cognitive health and related factors in elderly at risk for developing Alzheimer’s dementia: A longitudinal cohort study. The Journal of Prevention of Alzheimer’s Disease, 6(4), 256–266. https://doi.org/10.14283/JPAD.2019.31
   PubMed Web of Science ®Google Scholar
• Udeh-Momoh, C. T., Price, G. J., Robb, C., Bassil, D., Ward, H., Perneczky, R., … Middleton, L. T. (2017). Late-life Alzheimer’s disease-related factors as determinants of neurocognitive trajectories: Data from the cognitive health in ageing register for investigational and observational trials prospective readiness cohort (CHARIOT PRO) main study. Alzheimer’s & Dementia, 13(7), P1332. https://doi.org/10.1016/j.jalz.2017.06.2048
   Google Scholar
• Wisdom, N. M., Callahan, J. L., & Hawkins, K. A. (2011). The effects of apolipoprotein E on non-impaired cognitive functioning: A meta-analysis. Neurobiology of Aging, 32(1), 63–74. https://doi.org/10.1016/j.neurobiolaging.2009.02.00
   PubMed Web of Science ®Google Scholar